SEM
EW icon

Suncoast Equity Management’s Edwards Lifesciences EW Stock Holding History

Suncoast Equity Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$877K Sell
9,700
-645
-6% -$54K 0.11% 48
2026
Q1 		$828K Sell
10,345
-2,818
-21% -$232K 0.1% 54
2025
Q4 		$1.12M Sell
13,163
-460
-3% -$37.8K 0.11% 51
2025
Q3 		$1.06M Buy
13,623
+335
+3% +$26.2K 0.11% 53
2025
Q2 		$1.04M Buy
13,288
+535
+4% +$39.9K 0.11% 52
2025
Q1 		$924K Buy
12,753
+1,860
+17% +$133K 0.1% 51
2024
Q4 		$806K Buy
10,893
+1,388
+15% +$97.1K 0.09% 45
2024
Q3 		$627K Buy
9,505
+31
+0.3% +$2.25K 0.07% 54
2024
Q2 		$875K Buy
9,474
+589
+7% +$52.2K 0.1% 45
2024
Q1 		$849K Buy
8,885
+420
+5% +$35.3K 0.1% 45
2023
Q4 		$645K Buy
8,465
+15
+0.2% +$1.04K 0.09% 48
2023
Q3 		$585K Buy
8,450
+295
+4% +$23.7K 0.09% 46
2023
Q2 		$769K Buy
8,155
+32
+0.4% +$2.78K 0.12% 39
2023
Q1 		$672K Buy
8,123
+888
+12% +$69.8K 0.11% 36
2022
Q4 		$540K Buy
7,235
+340
+5% +$26.2K 0.1% 37
2022
Q3 		$570K Sell
6,895
-950
-12% -$91.4K 0.11% 32
2022
Q2 		$746K Buy
7,845
+315
+4% +$32.6K 0.13% 30
2022
Q1 		$886K Buy
7,530
+4,670
+163% +$524K 0.13% 31
2021
Q4 		$371K Buy
2,860
+205
+8% +$23.9K 0.05% 36
2021
Q3 		$301K Buy
2,655
+385
+17% +$43.9K 0.04% 37
2021
Q2 		$235K Buy
+2,270
New +$214K 0.03% 45
2021
Q1 		– Sell
-2,270
Closed -$207K – 45
2020
Q4 		$207K Buy
+2,270
New +$188K 0.03% 46
2020
Q1 		– Sell
-3,300
Closed -$257K – 45
2019
Q4 		$257K Buy
+3,300
New +$258K 0.05% 43

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Suncoast Equity Management's EW Position: Q2 2026 in Review

Suncoast Equity Management reduced its Edwards Lifesciences (EW) stake by 6.2% in Q2 2026, selling an estimated $54K and leaving 9,700 shares worth $877K. The position accounts for 0.11% of the portfolio, ranked #48.

Suncoast Equity Management first reported a position in EW in Q4 2019 and has held it in 23 quarters since. The position peaked at $1.12M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Suncoast Equity Management held 9,700 shares of Edwards Lifesciences worth $877K as of Q2 2026.
  • Suncoast Equity Management sold 645 Edwards Lifesciences shares in Q2 2026, an estimated $54K.
  • Edwards Lifesciences made up 0.11% of Suncoast Equity Management's portfolio in Q2 2026, its #48 holding.
  • Suncoast Equity Management first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 23 quarters since.
  • Suncoast Equity Management's Edwards Lifesciences position peaked at $1.12M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Suncoast Equity Management's 13F filing for Q2 2026, filed 4 Aug 2026.